Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.08 | 0.6 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.07 | 0.6 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |